ETFs positioned on Vertex Pharmaceuticals Incorporated

Name YTD change Weight AuM
+13.34%-.--% 44,934 M€
+13.66%-.--% 35,761 M€
+11.10%-.--% 28 M€
+0.50%-.--% 33 M€
+15.21%-.--% 33 M€
+8.55%-.--% 37 M€
+1.88%-.--% 49 M€
+11.90%-.--% 66 M€
+11.17%-.--% 67 M€
+8.98%-.--% 75 M€
+5.19%-.--% 80 M€
+11.25%-.--% 122 M€
+3.33%-.--% 293 M€
+13.65%-.--% 27,154 M€
+14.21%-.--% 750 M€
+13.74%-.--% 507 M€
+4.18%-.--% 165 M€
+13.38%-.--% 148 M€
+20.91%9.51% 15 M€
+27.40%9.43% 429 M€
+25.89%9.05% 78 M€
+25.99%9.05% 1,079 M€
+25.57%8.88% 9,953 M€
+26.95%8.54% 81 M€
+13.42%4.47% 7 M€
+6.88%4.4% 28 M€
+23.27%4.33% 11 M€
+40.79%4.15% 58 M€
+41.37%4.13% 87 M€
Logo Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated specializes in the research, development and marketing of micromolecular drugs primarily for the treatment of cancers, viral, inflammatory and auto-immune diseases. Net sales are distributed geographically as follows: the United States (62.9%), Europe (28.8%) and other (8.3%).
Employees
6,400
  1. Stock Market
  2. Stocks
  3. VRTX Stock
  4. ETFs Vertex Pharmaceuticals Incorporated
40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!